RecruitingEarly Phase 1NCT07294521

Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pak Emirates Military Hospital
Principal Investigator
Prof. Moizza Tahir, MBBS, FCPS, FRCP
Pak Emirates Military Hospital
Intervention
Platelet rich Fibrin (PRF)(biological)
Enrollment
40 target
Eligibility
35 years · All sexes
Timeline
20252026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07294521 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials